- call +1-201-465-4211
- email sales@mrinsights.biz
Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.
Scope of the Report:
This report studies the Gonorrhea Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gonorrhea Diagnostics market by product type and applications/end industries.
There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.
The growing use of molecular diagnostics for performing gonorrhea tests is a key trend in this market. Some of the new technologies in molecular diagnostics include PCR-based techniques, nucleic acid amplification tests, and DNA nanotechnology. As a result of the high efficiency, variety, accuracy, and reliability of these gonorrhea tests, the growing use of molecular diagnostics is expected to have a positive impact on the growth of the global gonorrhea diagnostics market during the forecast period.
The Americas accounted for 48% share of the gonorrhea diagnostics market during 2015 and is expected to retain its market dominance during the forecast period. The US is the largest revenue contributor for the sales of gonorrhea diagnosis products. Factors such as the high prevalence of gonorrhea disease, shift to molecular diagnostic tests, and increasing FDA approvals for new products will result in this region’s growth during the forecast period.
The global Gonorrhea Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gonorrhea Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
bioMérieux
PerkinElmer
Ortho Clinical Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chromatography
Diagnostic Imaging
Differential Light Scattering
Flow Cytometry
Gel Microdroplets
Immunoassay
Molecular Diagnostics
Monoclonal Antibodies Test
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Clinics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Gonorrhea Diagnostics Market Overview
1.1 Product Overview and Scope of Gonorrhea Diagnostics
1.2 Classification of Gonorrhea Diagnostics by Types
1.2.1 Global Gonorrhea Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Gonorrhea Diagnostics Revenue Market Share by Types in 2017
1.2.3 Chromatography
1.2.4 Diagnostic Imaging
1.2.5 Differential Light Scattering
1.2.6 Flow Cytometry
1.2.7 Gel Microdroplets
1.2.8 Immunoassay
1.2.9 Molecular Diagnostics
1.2.10 Monoclonal Antibodies Test
1.3 Global Gonorrhea Diagnostics Market by Application
1.3.1 Global Gonorrhea Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Clinics
1.3.6 Others
1.4 Global Gonorrhea Diagnostics Market by Regions
1.4.1 Global Gonorrhea Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Gonorrhea Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gonorrhea Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gonorrhea Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Gonorrhea Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gonorrhea Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Gonorrhea Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Gonorrhea Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Beckman Coulter
2.2.1 Business Overview
2.2.2 Gonorrhea Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Beckman Coulter Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche Diagnostics
2.3.1 Business Overview
2.3.2 Gonorrhea Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Diagnostics Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Siemens
2.4.1 Business Overview
2.4.2 Gonorrhea Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Siemens Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 bioMérieux
2.5.1 Business Overview
2.5.2 Gonorrhea Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 bioMérieux Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 PerkinElmer
2.6.1 Business Overview
2.6.2 Gonorrhea Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 PerkinElmer Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ortho Clinical Diagnostics
2.7.1 Business Overview
2.7.2 Gonorrhea Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ortho Clinical Diagnostics Gonorrhea Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Gonorrhea Diagnostics Market Competition, by Players
3.1 Global Gonorrhea Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Gonorrhea Diagnostics Players Market Share
3.2.2 Top 10 Gonorrhea Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Gonorrhea Diagnostics Market Size by Regions
4.1 Global Gonorrhea Diagnostics Revenue and Market Share by Regions
4.2 North America Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Gonorrhea Diagnostics Revenue by Countries
5.1 North America Gonorrhea Diagnostics Revenue by Countries (2013-2018)
5.2 USA Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Gonorrhea Diagnostics Revenue by Countries
6.1 Europe Gonorrhea Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Gonorrhea Diagnostics Revenue by Countries
7.1 Asia-Pacific Gonorrhea Diagnostics Revenue by Countries (2013-2018)
7.2 China Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Gonorrhea Diagnostics Revenue by Countries
8.1 South America Gonorrhea Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Gonorrhea Diagnostics by Countries
9.1 Middle East and Africa Gonorrhea Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Gonorrhea Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Gonorrhea Diagnostics Market Segment by Type
10.1 Global Gonorrhea Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Gonorrhea Diagnostics Market Forecast by Type (2018-2023)
10.3 Chromatography Revenue Growth Rate (2013-2023)
10.4 Diagnostic Imaging Revenue Growth Rate (2013-2023)
10.5 Differential Light Scattering Revenue Growth Rate (2013-2023)
10.6 Flow Cytometry Revenue Growth Rate (2013-2023)
10.7 Gel Microdroplets Revenue Growth Rate (2013-2023)
10.8 Immunoassay Revenue Growth Rate (2013-2023)
10.9 Molecular Diagnostics Revenue Growth Rate (2013-2023)
10.10 Monoclonal Antibodies Test Revenue Growth Rate (2013-2023)
11 Global Gonorrhea Diagnostics Market Segment by Application
11.1 Global Gonorrhea Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Gonorrhea Diagnostics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
11.6 Clinics Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Gonorrhea Diagnostics Market Size Forecast (2018-2023)
12.1 Global Gonorrhea Diagnostics Market Size Forecast (2018-2023)
12.2 Global Gonorrhea Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Gonorrhea Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Gonorrhea Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Gonorrhea Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Gonorrhea Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Gonorrhea Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Gonorrhea Diagnostics Picture
Table Product Specifications of Gonorrhea Diagnostics
Table Global Gonorrhea Diagnostics and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
